News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Arcus Biosciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Bay Area’s Arcus Biosciences Scores $107M, Initiates Two Clinical Trials
Now totaling $227M, Arcus Biosciences announced it had closed a $107M Series C financing.
November 13, 2017
·
2 min read
·
Mark Terry
Business
Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma
September 20, 2017
·
2 min read
Business
Arcus Biosciences, Wuxi Biologics Hammer Out R&D Cancer Pact Worth $816 Million+
August 17, 2017
·
2 min read
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
·
11 min read
·
Mark Terry
Business
What You Need to Know About Arcus Biosciences
January 3, 2017
·
5 min read
Business
Bay Area Startup Arcus Biosciences Emerges With $120 Million
August 29, 2016
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer
October 24, 2024
·
10 min read
Business
Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update
October 22, 2024
·
1 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - October 9, 2024
October 10, 2024
·
1 min read
Press Releases
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
October 9, 2024
·
7 min read
News
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
October 2, 2024
·
5 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - September 24, 2024
September 25, 2024
·
1 min read
Press Releases
Arcus Biosciences Announces New Employment Inducement Grants - September 10, 2024
September 11, 2024
·
1 min read
Drug Development
Gilead and Arcus Announce Etrumadenant Plus Zimberelimab Regimen Significantly Reduced the Risk of Death in Third-line Metastatic Colorectal Cancer
June 2, 2024
·
11 min read
BioForest
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
June 1, 2024
·
12 min read
Biotech Bay
Arcus Biosciences Announces New Employment Inducement Grants - May 24, 2024
May 24, 2024
·
1 min read
